nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
AGTR2 absence or antagonism prevents cystic fibrosis pulmonary manifestations
|
Darrah, Rebecca J. |
|
2019 |
18 |
1 |
p. 127-134 |
artikel |
2 |
Anaemia and iron deficiency in relation to fatigue in cystic fibrosis
|
Talbot, Nick P. |
|
2019 |
18 |
1 |
p. e5 |
artikel |
3 |
Authors’ response: Letter to the Editor ‘Anaemia and iron deficiency in relation to fatigue in cystic fibrosis’
|
Nap-van der Vlist, M.M. |
|
2019 |
18 |
1 |
p. e6-e7 |
artikel |
4 |
Breathlessness catastrophizing relates to poorer quality of life in adults with cystic fibrosis
|
Maras, Danijela |
|
2019 |
18 |
1 |
p. 150-157 |
artikel |
5 |
CFTR modulator theratyping: Current status, gaps and future directions
|
Clancy, John Paul |
|
2019 |
18 |
1 |
p. 22-34 |
artikel |
6 |
Continuous glucose monitoring in youth with cystic fibrosis treated with lumacaftor-ivacaftor
|
Li, Angel |
|
2019 |
18 |
1 |
p. 144-149 |
artikel |
7 |
Editorial Board
|
|
|
2019 |
18 |
1 |
p. ii |
artikel |
8 |
Editor in Chief Job Description for JCF_ElsevierDec18_Final
|
|
|
2019 |
18 |
1 |
p. v-vi |
artikel |
9 |
Effectiveness of ivacaftor in cystic fibrosis patients with non-G551D gating mutations
|
Guimbellot, Jennifer |
|
2019 |
18 |
1 |
p. 102-109 |
artikel |
10 |
Emergence of livestock-associated MRSA isolated from cystic fibrosis patients: Result of a Belgian national survey
|
Dodémont, M. |
|
2019 |
18 |
1 |
p. 86-93 |
artikel |
11 |
Eradication of early P. aeruginosa infection in children <7 years of age with cystic fibrosis: The early study
|
Ratjen, Felix |
|
2019 |
18 |
1 |
p. 78-85 |
artikel |
12 |
Establishment of a ΔF508-CF promyelocytic cell line for cystic fibrosis research and drug screening
|
Jennings, Scott |
|
2019 |
18 |
1 |
p. 44-53 |
artikel |
13 |
Higher Interleukin-7 serum concentrations in patients with cystic fibrosis correlate with impaired lung function
|
Seyfarth, Julia |
|
2019 |
18 |
1 |
p. 71-77 |
artikel |
14 |
How to live a long and healthy life with cystic fibrosis: Lessons from the CF ferret
|
Wine, Jeffrey J. |
|
2019 |
18 |
1 |
p. 8-9 |
artikel |
15 |
Investigating the effects of long-term dornase alfa use on lung function using registry data
|
Newsome, S.J. |
|
2019 |
18 |
1 |
p. 110-117 |
artikel |
16 |
Italian and North American dietary intake after ivacaftor treatment for Cystic Fibrosis Gating Mutations
|
Sainath, Nina N. |
|
2019 |
18 |
1 |
p. 135-143 |
artikel |
17 |
JCF – progress in 2018
|
Bell, Scott C. |
|
2019 |
18 |
1 |
p. 1-5 |
artikel |
18 |
Lumacaftor/Ivacaftor reduces pulmonary exacerbations in patients irrespective of initial changes in FEV1
|
McColley, Susanna A. |
|
2019 |
18 |
1 |
p. 94-101 |
artikel |
19 |
Newborn blood spot screening for cystic fibrosis with a four-step screening strategy in the Netherlands
|
Dankert-Roelse, Jeannette E. |
|
2019 |
18 |
1 |
p. 54-63 |
artikel |
20 |
News
|
|
|
2019 |
18 |
1 |
p. 10-12 |
artikel |
21 |
Resistin is elevated in cystic fibrosis sputum and correlates negatively with lung function
|
Forrest, Osric A. |
|
2019 |
18 |
1 |
p. 64-70 |
artikel |
22 |
Respiratory rate in infants with cystic fibrosis throughout the first year of life and association with lung clearance index measured shortly after birth
|
Korten, Insa |
|
2019 |
18 |
1 |
p. 118-126 |
artikel |
23 |
Successful Lung Re-transplant in a Patient with Cepacia Syndrome due to Burkholderia ambifaria
|
Goodlet, Kellie J. |
|
2019 |
18 |
1 |
p. e1-e4 |
artikel |
24 |
Take it personally: how personal we reach when we are so different from each other?
|
Kerem, Eitan |
|
2019 |
18 |
1 |
p. 6-7 |
artikel |
25 |
The CF Canada-Sick Kids Program in individual CF therapy: A resource for the advancement of personalized medicine in CF
|
Eckford, Paul D.W. |
|
2019 |
18 |
1 |
p. 35-43 |
artikel |
26 |
The lung and gut microbiome: what has to be taken into consideration for cystic fibrosis?
|
Héry-Arnaud, Geneviève |
|
2019 |
18 |
1 |
p. 13-21 |
artikel |